Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
9.27
+0.05 (0.54%)
Mar 14, 2025, 10:41 AM EDT - Market open
Intellia Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 960 | 1,188 | 2,731 | 2,974 | 8,799 | 3,514 | |
| Market Cap Growth | -56.51% | -56.51% | -8.18% | -66.20% | 150.41% | 390.02% | |
| Enterprise Value | 324 | 344 | 1,856 | 2,223 | 7,727 | 3,128 | |
| Last Close Price | 9.22 | 11.66 | 30.49 | 34.89 | 118.24 | 54.40 | |
| PS Ratio | 15.75 | 20.52 | 75.27 | 57.06 | 266.22 | 60.59 | |
| PB Ratio | 1.08 | 1.36 | 2.60 | 2.41 | 8.46 | 6.67 | |
| P/TBV Ratio | 1.36 | 1.36 | 2.60 | 2.41 | 8.46 | 6.67 | |
| EV/Sales Ratio | 5.60 | 5.95 | 51.17 | 42.65 | 233.76 | 53.94 | |
| Debt / Equity Ratio | 0.24 | 0.24 | 0.11 | 0.11 | 0.07 | 0.07 | |
| Asset Turnover | 0.05 | 0.05 | 0.03 | 0.04 | 0.03 | 0.11 | |
| Quick Ratio | 5.50 | 5.50 | 8.23 | 9.45 | 5.97 | 9.33 | |
| Current Ratio | 5.77 | 5.77 | 8.67 | 9.61 | 6.11 | 9.59 | |
| Return on Equity (ROE) | -54.00% | -54.00% | -42.10% | -41.67% | -34.18% | -33.69% | |
| Return on Assets (ROA) | -26.80% | -26.80% | -22.83% | -20.35% | -16.99% | -16.89% | |
| Return on Capital (ROIC) | -29.71% | -29.71% | -25.44% | -23.09% | -19.92% | -19.98% | |
| Earnings Yield | -53.20% | -43.71% | -17.62% | -15.95% | -3.04% | -3.82% | |
| FCF Yield | -36.35% | -29.86% | -14.94% | -11.66% | -2.70% | -1.52% | |
| Buyback Yield / Dilution | -11.35% | -11.35% | -15.33% | -8.57% | -26.63% | -18.50% | |
| Total Shareholder Return | -11.35% | -11.35% | -15.33% | -8.57% | -26.63% | -18.50% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.